All Real World Research ACCCBuzz Articles

LUNGevity Health Equity Summit: A Focus on Biomarker Testing

April 11, 2024

LUNGevity invited ACCC and other stakeholders across the oncology world to Washington DC, for their second Health Equity Summit on Tuesday, March 12.

Hand Stacking Healthcare Items_ACCCBuzz_Square

ACCC Recognizes National Cancer Prevention and Early Detection Month

April 09, 2024

ACCC recognizes April as National Cancer Prevention and Early Detection Month.

Breast Cancer Ribbon in Hands_ACCCBuzz_Square

Clinical Meaningfulness: Insights from a Metastatic Breast Cancer Qualitative Study

March 21, 2024

Explore findings from a multi-stakeholder collaboration aimed at exploring clinical meaningfulness in comprehensive care delivery for patients with metastatic breast cancer.

ACCC & Inova Schar Cancer Institute Meet with Swedish Delegates

By Molly Kisiel, MSN, FNP-BC
March 14, 2024

Explore key takeaways from a meeting between ACCC, Inova Schar Cancer Institute, and delegates from the Swedish Ministry of Health and Social Affairs.

#AMCCBS: Recognizing Excellence + Leadership Training

March 06, 2024

Highlights from the final day of the ACCC 50th Annual Meeting & Cancer Center Business Summit (#AMCCBS).

Examining Clinical Research for Patients with Acute Myeloid Leukemia

January 30, 2024

Evaluate recommendations on improving clinical trial diversity among patients with acute myeloid leukemia.

Social Drivers of Health: The Role of Representation in the Healthcare Workforce

By Rania Emara
January 15, 2024

This is the second post of a three-part series on Modern Healthcare’s Social Determinants of Health Symposium.

The Cost of Biomarker Testing: Moving from Support-based to Sustainable Solutions

December 12, 2023

ACCC, ACS CAN, and LUNGevity, launched a series of focus groups earlier this year aimed at making the case for increasing access to comprehensive genomic profiling for Medicaid beneficiaries.

Multidisciplinary Collaboration_ACCCBuzz_Square

EHR Integration: The Next Necessary Step for Optimized Cancer Care

November 17, 2023

At the ACCC 40th NOC, an exclusive EHR Working Summit was held to understand and explore effective practices/workaround solutions for streamlined biomarker test ordering and results management.

Researcher and Lab Testing_ACCCBuzz_Square

Comprehensive Cancer Care: The Role of Biomarker Testing

November 06, 2023

Equitable access to precision medicine should be a right to which all patients with cancer are entitled regardless of their insurance coverage or type. Read more about ACCC’s efforts to help Medicaid beneficiaries overcome financial barriers to biomarker testing.

Improving Care Delivery for Transplant-Ineligible Patients with Acute Myeloid Leukemia

October 24, 2023

ACCC in partnership with HealthTree Foundation for Acute Myeloid Leukemia, has launched an education program to explore the current barriers in care coordination and therapy options for patients with AML who are not eligible for transplant.

Highlights from the President’s Cancer Panel: Building on a Strong Legacy

October 12, 2023

ACCC president Olalekan Ajayi, PharmD, MBA, shared the association’s key priorities for impacting cancer care in the United States with the President’s Cancer Panel.

A Road Map for Newly Diagnosed Patients with Pancreatic Cancer

By Let's Win Team
September 26, 2023

Let’s Win Pancreatic Cancer provides a road map of resources to help newly diagnosed patients with pancreatic cancer obtain the resources they need throughout their care journey.

Light Bulb Idea with Collaboration_ACCCBuzz_Square

Precision Medicine in Rural and Underserved Areas: Unique Solutions for Unique Challenges

September 12, 2023

Through a series of education projects, ACCC is committed to providing the resources the multidisciplinary cancer care team will need to navigate the complex precision medicine landscape and deliver next generation cancer care.

The Road to Comprehensive Biomarker Testing for All

August 31, 2023

In the era of personalized medicine, biomarker testing is a tool the oncology workforce can and should leverage to deliver next generation cancer care.

Closing the Testing Gap: Standardization of Comprehensive Biomarker Testing in NSCLC

August 25, 2023

Oncology Hematology Care, Inc. launched a one-year quality improvement project to implement and standardize comprehensive biomarker testing in patients with metastatic non-small cell lung cancer.

Pancreatic Cancer: Why Clinical Trials Should Be a Patient’s Starting Point

By The Let's Win Team
August 15, 2023

For patients with pancreatic cancer, clinical trials should be considered as a possible treatment option early on, not a last resort when all else fails. The Let's Win team discusses why.

Quality Highlighted in Pink_ACCCBuzz_Square

Regional Disparities in Chronic Lymphocytic Leukemia: A GPS for Cancer Care

June 22, 2023

ACCC set out to identify and understand specific regional challenges to appropriate and equitable care for patients with chronic lymphocytic leukemia, the most common form of leukemia in adults.

Let’s Win Pancreatic Cancer: A Partner for Patients and Care Teams

By The Let's Win Team
June 13, 2023

Let’s Win Pancreatic Cancer is an advocacy organization that works with patients, providers, and researchers to share the latest information and treatment options for pancreatic cancer.

ACCC Recognizes National Cancer Research Month

May 23, 2023

ACCCBuzz spoke with Erika Siegrist at Luminis Health Research Institute to learn more about how technology has helped expand patient access to cancer clinical trials.

Colorful Hands Coming Together_ACCCBuzz_Square

2023 NMQF Summit: Patient Education to Achieve Health Equity

May 10, 2023

As efforts to promote health equity continue to grow, educating patients with cancer about the importance of clinical trials and cancer screenings is of the utmost importance.

2023 NMQF Summit: Improving Diversity in Cancer Clinical Trials

May 03, 2023

At the 2023 National Minority Quality Forum Summit on Health Disparities and Spring Health Braintrust, panelists discussed strategies that can be implemented to improve diversity in clinical trials.

#AMCCBS: Clinical & Operational Updates in Oncology

March 09, 2023

Before opening the ACCC 49th Annual Meeting & Cancer Center Business Summit to its membership, ACCC held two pre-conference events on Wednesday, March 8. Learn more about what was discussed among invited speakers during these events.

ACCC Announces its 2023 Advocacy Agenda

March 07, 2023

For 2023, ACCC members have identified four core areas of focus (e.g., reimbursement, utilization management, provider-patient choice), among a larger set of issues and concerns, that the association will be supporting this year.

Precision Medicine: Stories from the CRISPR Revolution

January 31, 2023

Dr. Kevin Davies previews his opening keynote at the upcoming Association of Community Cancer Centers (ACCC) 49th Annual Meeting & Cancer Center Business Summit (AMCCBS).

Recognizing National Nurse Practitioner Week Through Thought Leaders

November 16, 2022

November 13 to 19 is dedicated to National Nurse Practitioner Week, and the Association of Community Cancer Centers (ACCC) is taking this opportunity to recognize its nurse practitioner (NP) members—highlighting the work NPs do to improve access to care, the patient and clinician experience, and patient outcomes.

#ACCCNOC: Honoring Awardees + Supporting the Oncology Workforce

October 19, 2022

ACCC President Dr. David Penberthy, honors the 2022 ACCC Award winners for their significant contributions to the oncology community. Speakers share key strategies to enhance the role of the oncology pharmacist and prepare for population health in oncology.

#ACCCNOC: What Does the Future of Cancer Care Look Like?

October 13, 2022

The ACCC 39th National Oncology Conference opened with two pre-conferences, covering financial advocacy in oncology and the future of cancer care. Learn what care delivery may look like in 2040 and how ACCC is supporting cancer programs and practices through its Financial Advocacy Network.

ACCC Recognizes Prostate Cancer Awareness Month

September 21, 2022

In recognition of September as prostate cancer month, ACCCBuzz reviews the current landscape of prostate cancer care.

Riding to Victory: One Man’s Journey to Surviving Cancer

July 28, 2022

Tom Vibert was diagnosed with Stage 4 metastatic colon cancer in 2014. Learn how participating in a clinical trial allowed Vibert to get back on the bike and beat his cancer.

2022 ACCC Hill Day: Members Meet with Congress

June 24, 2022

Advocating on behalf of their patients and programs, ACCC members from 14 states participated in Virtual Hill Day, speaking with Congress and their staff on key legislation asks regarding access to care, telehealth, prior authorizations, and more.

ACCC Forms Alliance to Improve Cancer Care Continuum

June 08, 2022

ACCC has partnered with several of its oncology state societies to establish the Appalachian Community Cancer Alliance—a key effort to address disparities in cancer screening and care delivery in the region.

Local Action Improves Access to Key Oncology Services

April 28, 2022

The second post in a three-blog series, ACCCBuzz shares how Carolina Blood and Cancer Care Associates' NOLA initiative is addressing access to care, clinical trials, biomarker testing, and more.

Act Locally: No One Is Left Alone

April 20, 2022

Carolina Blood and Cancer Care Associate's No One Left Alone (or NOLA) initiative is a multi-phase pilot program aimed at lessening disparities in cancer care in three key areas: care access, biomarker testing, and clinical trials.

ACCC Pursues Health Equity Through ACORI

October 05, 2021

In 2021, ACCC launched the ACCC Community Oncology Research Institute (ACORI), which builds on ACCC’s mission to achieve equitable cancer care for all patients by forming key community partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event held September 13-14, 2021, to garner participant feedback and guide the future of the institute.

Health Equity Summit: Conversations on Representation in Clinical Trials

September 30, 2021

Although clinical trials have been used for decades to determine the safety and efficacy of drugs and medical devices, the lack of a diverse population in such studies has failed to represent the population suffering the burden of the diseases being studied.

New Legislation Expands Access to Clinical Trials

By Matt Devino, MPH
July 14, 2021

Beginning January 2022, CMS will be required to cover for Medicaid patients the routine costs associated with participating in clinical trials. Learn what states and provider organizations can do to leverage this mandate to address barriers to care in the community and reduce inequities in clinical trial participation.

ACCC Raises Awareness for National Black Family Cancer Awareness Week

June 14, 2021

The U.S. Food and Drug Administration's Oncology Center of Excellence, Project Community, has designated June 17 to June 23 as National Black Family Cancer Awareness Week. The week coincides with Juneteenth—an important date in our nation’s history that marks and celebrates the end of slavery in the United States. By participating in the #BlackFamCan social media effort, ACCC is building support and sharing knowledge with key stakeholders about the importance of including Black patients in cancer clinical trials and genetic databases for oncology research to improve access and effect change in cancer care delivery.

City of Hope’s Investigational COVID-19 Vaccine

May 05, 2021

As City of Hope embarkes on the development of an experimental COVID-19 vaccine currently in a phase I clinical trial, ACCCBuzz spoke with Dr. Sanjeet Dadwal about the investigational vaccine’s safety and efficacy, potential emergency use authorization (EUA), and suitability for patients with cancer.

Older Adults with Cancer & Clinical Trials

April 27, 2021

Older adults with cancer are consistently precluded from participating in clinical trials for promising new treatments. A multi-pronged approach is required to ensure trials are developed for all patients, including paying specific attention to inclusion/exclusion criteria and creating clinically meaningful endpoints that can enhance enrollment efforts in underserved populations.

Taking Action on Disparities in Prostate Cancer

April 20, 2021

The disparities in prostate cancer are striking. In the United States, Black men continue to experience a far greater incidence of new prostate cancers and are 2.2 to 2.5 times more likely to die from the disease than any other racial/ethnic group. Taking action to close these gaps is an imperative for moving toward equitable cancer care.

The Role of Community Partners in Serving AYA Patients

By Lilibeth Torno, MD
April 01, 2021

Poor access to care among AYA patients is not only evident in low clinical trial enrollment. The struggle to access much-needed care continues when treatment concludes. Most AYA cancer survivors must learn to navigate follow-up medical care on their own.

Applying COVID-19 Lessons Learned to Improve Cancer Care & Research

March 18, 2021

The Road to Recovery Report makes specific recommendations for maintaining the adaptations made necessary to accommodate the disruptions caused by the pandemic. Where possible, the report recommends building on that momentum to spur much-needed change in cancer care and research.

People unitying as one by holding up colorful gears on blue background

Improving Access to Clinical Trials for Rural Populations

March 08, 2021

Montana is one of the most rural states in the U.S., with nearly half of its population living in rural regions. Accordingly, accessing healthcare services can be difficult for Montana’s citizens, and gaining access to clinical trials is particularly challenging.

Beyond COVID-19: The Road to Recovery

February 22, 2021

COVID-19 has highlighted how challenging it is for cancer care providers large and small when healthcare resources are limited. One oncologist shares her experience on a task force that drafted a series of recommendations for moving forward in cancer care as the pandemic recedes.

A Conversation With ASCO’s Dr. Richard Schilsky

January 28, 2021

ACCCBuzz sat down with ASCO's Dr. Richard L. Schilsky to look back on his career and look forward to the future breakthroughs in this era and beyond.

The Role of Patient Advocates in Clinical Research

January 25, 2021

Carla Strom, MLA, speaks with ACCCBuzz about her role as an advocate, how this role has evolved, and why listening to the community's voice early and often in clinical trial development and cancer research is vital.

Community Outreach to Address Disparities in Cancer Care

January 14, 2021

Learn how the PECaD program at Siteman Cancer Center is decreasing disparities in care by monitoring data, engaging the community, supporting research, and ensuring diverse representation in research.

Cartoon prescription pill bottle with two pills

Oncology Research in Community: Leveraging the Role of Pharmacist

January 12, 2021

In the final installment of ACCC’s webinar series honoring American Pharmacists Month, experts discussed the integral role pharmacists play in supporting clinical trial research in the community setting, and they identified opportunities for extending the pharmacist role in an increasingly complex research landscape.